Form 4 for BEAM Beam Therapeutics Inc.
Accepted 2025-02-20 00:00:00 ET · period of report 2025-02-18 · accession 0000950170-25-024149 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2025-02-20 | 2025-02-18 | BEAM | Cavanagh Bethany J | SVP, Fin, Treas | S - Sale | $35.00 | -6,287 | 37.5K | -14% | -$220.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-18 | S | D | 6,287 | $35.00 | 37,527 | D | — | — |